Rumsey W L, Wilson D F, Erecińska M
Department of Biochemistry, University of Pennsylvania School of Medicine, Philadelphia 19104.
Am J Physiol. 1987 Nov;253(5 Pt 2):H1098-105. doi: 10.1152/ajpheart.1987.253.5.H1098.
The hypothesis that extracellular [Ca2+] ([Ca2+]e) influences the transmission of vasoregulatory information from the heart to coronary smooth muscle was examined. The isolated, retrogradely perfused rat heart was used to evaluate vascular reactivity to transient infusion of either 0.88 mM Amytal (amobarbital), hypoxia (95% N2-5% CO2), or 12 microM adenosine in the presence and absence of 2.5 microM verapamil. Amytal alone enhanced coronary flow by 78% and lactate efflux by 10-fold, whereas it decreased O2 consumption by 40% and the ratio of the free cytosolic concentrations of ATP-to-ADP times the intracellular concentration of inorganic phosphate ([ATP]f/[ADP]f[Pi]) by 10-fold. These responses were attenuated by preperfusion with verapamil, i.e., flow and lactate efflux increased by 4% and fourfold, respectively, and O2 consumption and [ATP]f/[ADP]f/[Pi] decreased by 8% and threefold, respectively, as compared with values attained with verapamil at steady state. Washout of the calcium channel antagonist by perfusion for 55 min with a verapamil-free medium resulted in a return of metabolic variables to control levels. Subsequent infusion of Amytal induced metabolic changes that were similar to those obtained before exposure to the calcium antagonist, but flow rose only by 26%. Vascular responses to hypoxia were similarly modified, whereas those to adenosine were unaffected. Hearts perfused with media containing either low [Ca2+]e or 10 microM diltiazem and exposed to Amytal produced flow patterns analogous to those perfused with verapamil. These data, in part, distinguish changes in vascular resistance that occur in response to cardiac metabolism from those which result from agents with direct action on smooth muscle, in particular, adenosine.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了细胞外钙离子浓度([Ca2+]e)影响血管调节信息从心脏传递至冠状动脉平滑肌这一假说。采用离体逆行灌注大鼠心脏,在存在和不存在2.5微摩尔维拉帕米的情况下,评估血管对短暂输注0.88毫摩尔异戊巴比妥(异戊巴比妥钠)、缺氧(95% N2 - 5% CO2)或12微摩尔腺苷的反应性。单独使用异戊巴比妥可使冠状动脉血流量增加78%,乳酸流出量增加10倍,而氧气消耗量降低40%,游离胞质中ATP与ADP浓度之比乘以细胞内无机磷酸盐浓度([ATP]f/[ADP]f[Pi])降低10倍。维拉帕米预灌注可减弱这些反应,即与维拉帕米稳态时的值相比,血流量和乳酸流出量分别增加4%和4倍,氧气消耗量和[ATP]f/[ADP]f/[Pi]分别降低8%和3倍。用不含维拉帕米的培养基灌注55分钟以洗脱钙通道拮抗剂后,代谢变量恢复至对照水平。随后输注异戊巴比妥引起的代谢变化与暴露于钙拮抗剂之前相似,但血流量仅增加26%。对缺氧的血管反应也有类似改变,而对腺苷的反应未受影响。用含低[Ca2+]e或10微摩尔地尔硫䓬的培养基灌注并暴露于异戊巴比妥的心脏产生的血流模式与用维拉帕米灌注的心脏相似。这些数据部分区分了因心脏代谢引起的血管阻力变化与由直接作用于平滑肌的药物(特别是腺苷)导致的血管阻力变化。(摘要截取自250字)